Xanthine oxidase inhibitor formulations
US11406713B2 · kind B2 · utility
0Cited by
9References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 17, 2014 |
| Grant date | Aug 9, 2022 |
| Priority date | — |
| Expiry date | Mar 17, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods and compositions for involving a xanthine oxidase inhibitor that has enhanced solubility. The compositions described herein include a xanthine oxidase inhibitor combined with an organic base. The compositions can be used to treat a disease or medical condition that involves elevated uric acid levels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.